- Home
- RDY vs RVTY Comparison
RDY vs RVTY Comparison
Compare RDY & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDY | RVTY |
|---|---|---|
| Founded | 1984 | 1937 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.8B |
| IPO Year | 2001 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RDY | RVTY |
|---|---|---|
| Price | $13.34 | $89.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $16.90 | ★ $111.87 |
| AVG Volume (30 Days) | ★ 2.2M | 908.7K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | ★ 0.54% | 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $7.81 | $6.34 |
| Revenue Next Year | $3.20 | $5.14 |
| P/E Ratio | ★ $18.67 | $43.76 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.82 | $81.36 |
| 52 Week High | $16.17 | $118.30 |
Technical Indicators
Market Signals| Indicator | RDY | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 49.53 |
| Support Level | $13.32 | $88.73 |
| Resistance Level | $14.14 | $95.90 |
| Average True Range (ATR) | 0.23 | 2.96 |
| MACD | -0.04 | 0.93 |
| Stochastic Oscillator | 43.86 | 64.67 |
Price Performance
Historical ComparisonAbout RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.